- Home
- HE vs RXRX Comparison
HE vs RXRX Comparison
Compare HE & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$2.94
Company Overview
Basic Information| Metric | HE | RXRX |
|---|---|---|
| Founded | 1891 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HE | RXRX |
|---|---|---|
| Price | $13.27 | $2.94 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $13.25 | $7.50 |
| AVG Volume (30 Days) | 1.8M | ★ 10.4M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.32 | 14.79 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $3,086,896,000.00 | $74,681,000.00 |
| Revenue This Year | $7.00 | $12.11 |
| Revenue Next Year | $4.06 | $82.52 |
| P/E Ratio | $75.06 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $10.15 | $2.80 |
| 52 Week High | $17.33 | $7.18 |
Technical Indicators
Market Signals| Indicator | HE | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 27.98 | 34.66 |
| Support Level | $10.92 | $2.89 |
| Resistance Level | $13.41 | $3.99 |
| Average True Range (ATR) | 0.50 | 0.18 |
| MACD | -0.23 | -0.05 |
| Stochastic Oscillator | 4.65 | 0.00 |
Price Performance
Historical Comparison HE
RXRX
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.